Although the target gene/pathways remains to be experimentally determined, we demonstrated here that inhibition of specific DLK1-miRNAs with antagomirs reduced the production of lupus-relevant cytokines in LPS-activated splenocytes from MRL-lpr mice. The gene discussed is DLK1; the disease is systemic lupus erythematosus.